Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03RJZ
|
|||
| Former ID |
DIB010778
|
|||
| Drug Name |
Oxeglitazar
|
|||
| Synonyms |
EMD-336340; EML-16156; EML-4156; LM-4156
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Gout [ICD-11: FA25; ICD-10: M10] | Phase 1 | [1] | |
| Company |
Merck Sante SA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H22O4
|
|||
| Canonical SMILES |
CC(=CC(=O)O)C=CC1=CC(COC2=C1C=C(C=C2)OC)(C)C
|
|||
| InChI |
1S/C19H22O4/c1-13(9-18(20)21)5-6-14-11-19(2,3)12-23-17-8-7-15(22-4)10-16(14)17/h5-11H,12H2,1-4H3,(H,20,21)/b6-5+,13-9+
|
|||
| InChIKey |
FVGXANXBVWECQE-BYWGDBCOSA-N
|
|||
| CAS Number |
CAS 280585-34-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Therapeutic potential of aleglitazar, a new dual PPAR-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. Am J Cardiovasc Drugs. 2010;10(4):209-16. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.